-
Influenza Hemagglutinin (HA) Peptide in EV Studies
2026-09-23
Explore how the Influenza Hemagglutinin (HA) Peptide can turn HA-tagged protein recovery into a precise assay-design variable for exosome and extracellular-vesicle research. This article connects competitive elution, tag accessibility, and the RAB31-dependent ESCRT-independent pathway while clearly separating established evidence from workflow recommendations.
-
SB-3CT: Causal Assays for MMP-9 and ECM
2026-09-22
SB-3CT is a selective gelatinase inhibitor for testing how MMP-2 and MMP-9 reshape extracellular matrix biology. This article develops a causal assay framework linking Adamtsl3–MMP9–perineuronal-net findings to tumor metastasis research, angiogenesis inhibition, and neuroprotection in cerebral ischemia.
-
Novel FLCN Mutations and mRNA Rescue in BHD
2026-09-22
This 2026 study identifies the FLCN p.Q44* mutation and provides functional and co-segregation evidence that p.W376R is pathogenic in two Chinese families with Birt-Hogg-Dubé syndrome. Its cell-based rescue experiments also offer preliminary support for FLCN mRNA supplementation as a protein-replacement strategy, although the approach remains preclinical.
-
Influenza Hemagglutinin (HA) Peptide Workflows
2026-09-21
Use the Influenza Hemagglutinin (HA) Peptide as a practical competitive-elution reagent for HA-tagged protein detection, immunoprecipitation, and interaction studies. Its high purity, broad solubility, and compatibility with Anti-HA Magnetic Beads support workflows that preserve native complexes while enabling targeted recovery.
-
EZ Cap™ Cre mRNA (m1Ψ) Workflow Guide
2026-09-21
Build transient, quantifiable Cre-lox assays with a Cap 1, m1Ψ-modified, polyadenylated transcript designed for efficient translation and reduced innate immune activation. This guide connects practical delivery workflows with extrahepatic mRNA-platform development while separating validated findings from forward-looking assay applications.
-
Cy5 TSA Fluorescence System Kit for Astrocyte Maps
2026-09-20
The Cy5 TSA Fluorescence System Kit converts transcriptomic astrocyte hypotheses into high-sensitivity spatial assays. Learn how HRP-driven tyramide deposition supports immunohistochemistry, immunocytochemistry, and in situ hybridization while preserving regional and developmental context.
-
HyperFluor 488 Goat Anti-Mouse IgG Guide
2026-09-19
HyperFluor 488 Goat Anti-Mouse IgG is a fluorescently labeled secondary antibody for detecting mouse IgG in immunofluorescence, flow cytometry, and western blotting. Its H+L binding profile supports signal amplification, while the K1204 formulation provides defined concentration, buffer, and storage conditions.
-
EZ Cap™ Cre mRNA (m1Ψ) for Gene Editing
2026-09-18
EZ Cap™ Cre mRNA (m1Ψ) is a Cap 1, polyadenylated Cre recombinase mRNA designed for transient loxP recombination studies. Its m1Ψ modification, RNase-controlled handling, and low-temperature storage support gene editing mRNA workflows in vitro and in vivo.
-
EPZ5676: From DOT1L Blockade to Immune Signaling
2026-09-18
Explore how EPZ5676, a highly selective DOT1L inhibitor, connects H3K79 methylation inhibition with leukemia biology and emerging innate immune mechanisms in multiple myeloma. This article translates recent evidence into a decision framework for mechanistic assays, combination studies, and rigorous interpretation.
-
Wnt–BMP Patterning in Ptychodera flava
2026-09-17
Le Petillon and colleagues define how Wnt and BMP signals coordinate anterior neuroectoderm formation in the indirect-developing hemichordate Ptychodera flava. The study identifies posterior Wnt activity as an anterior-restricting cue and reveals a biphasic role for BMP, providing a useful comparative framework for deuterostome axis and neural patterning studies.
-
Salinomycin Workflows for HCC Drug Response
2026-09-17
Build clearer hepatocellular carcinoma assays by separating growth inhibition from actual cell killing. This Salinomycin workflow combines viability, apoptosis, calcium, cell-cycle, and Wnt/β-catenin readouts to improve mechanistic interpretation and troubleshooting.
-
SLC2A5 Fructose Metabolism in Primary CNS Lymphoma
2026-09-16
This Advanced Science study combines single-cell RNA sequencing, B-cell receptor profiling, and functional perturbation experiments to identify SLC2A5-mediated fructose metabolism as an adaptive feature of primary central nervous system lymphoma. The findings connect glucose-poor, hypoxic tumor niches with malignant-cell metabolism, macrophage support, and T-cell dysfunction, while highlighting SLC2A5 as a potential therapeutic vulnerability.
-
SB743921 Workflow for KSP-Targeted Cancer Research
2026-09-16
SB743921 is a selective kinesin spindle protein inhibitor for separating mitotic arrest, growth inhibition, and cell death in cancer models. This workflow combines concentration-controlled dosing with time-resolved viability, imaging, and apoptosis measurements to improve interpretation across cell lines and tumor xenograft models.
-
Sodium dicloxacillin monohydrate in MSSA assays
2026-09-15
Sodium dicloxacillin monohydrate supports controlled MSSA inhibition studies that distinguish extracellular killing from intracellular persistence. This guide translates published PK/PD findings into practical assay workflows, concentration planning, and troubleshooting strategies for Gram-positive bacterial infection research.
-
Cardiogreen (Indocyanine Green) for PDT & Imaging
2026-09-15
Cardiogreen (Indocyanine green) combines near-infrared vascular imaging with a practical photosensitizer workflow for cell-based photodynamic therapy. This guide translates its diagnostic strengths into reproducible bench assays while showing how recent oral cancer immunology findings can inform assay design without overstating clinical readiness.